Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2025 ,inter alia, to consider and approve the meeting ....
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indraprastha Medical Corporation Ltd, which operates Indraprastha Apollo Hospitals in Delhi, has informed the stock exchanges that its Board of Directors will meet on Saturday, 1st November 2025. The main item on the agenda is to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2025 (i.e., Q2 FY26 and H1 FY26 results). The intimation was filed on 17th October 2025 under SEBI's Listing Regulations by the Company Secretary, Priya Ranjan. The stock trades under scrip code 532150 on BSE and symbol INDRAMEDCO on NSE.
This is a routine advance intimation with no immediate impact on the stock. Investors should watch for the Q2/H1 FY26 results announcement on or shortly after 1st November 2025, which will provide insights into the hospital's revenue growth, occupancy, and margins for the first half of the financial year.